These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 18174972

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Pharmacokinetic and pharmacodynamic evaluation of raltegravir and experience from clinical trials in HIV-positive patients.
    Calcagno A, D'Avolio A, Bonora S.
    Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1167-76. PubMed ID: 26073580
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.
    Buzón MJ, Massanella M, Llibre JM, Esteve A, Dahl V, Puertas MC, Gatell JM, Domingo P, Paredes R, Sharkey M, Palmer S, Stevenson M, Clotet B, Blanco J, Martinez-Picado J.
    Nat Med; 2010 Apr; 16(4):460-5. PubMed ID: 20228817
    [Abstract] [Full Text] [Related]

  • 25. Raltegravir: a review of its pharmacokinetics, pharmacology and clinical studies.
    Burger DM.
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1151-60. PubMed ID: 20701552
    [Abstract] [Full Text] [Related]

  • 26. Expanded access drug profile: raltegravir (RAL, MK-0518).
    Colquitt AR, Pham PA.
    Hopkins HIV Rep; 2007 Jan; 19(1):11-2. PubMed ID: 17569171
    [No Abstract] [Full Text] [Related]

  • 27. Raltegravir, a new HIV integrase inhibitor.
    Gandhi RT.
    AIDS Clin Care; 2007 Dec; 19(12):105. PubMed ID: 18399003
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Two new drugs for HIV infection.
    Med Lett Drugs Ther; 2008 Jan 14; 50(1277):2-4. PubMed ID: 18197163
    [No Abstract] [Full Text] [Related]

  • 31. Treatment of HIV infection with raltegravir.
    Chirch LM, Morrison S, Steigbigel RT.
    Expert Opin Pharmacother; 2009 May 14; 10(7):1203-11. PubMed ID: 19385721
    [Abstract] [Full Text] [Related]

  • 32. Anti-HIV agents. Integrase inhibitor raltegravir makes its mark.
    TreatmentUpdate; 2007 Feb 14; 19(2):8-9. PubMed ID: 17447316
    [No Abstract] [Full Text] [Related]

  • 33. Characterization and structural analysis of HIV-1 integrase conservation.
    Ceccherini-Silberstein F, Malet I, D'Arrigo R, Antinori A, Marcelin AG, Perno CF.
    AIDS Rev; 2009 Feb 14; 11(1):17-29. PubMed ID: 19290031
    [Abstract] [Full Text] [Related]

  • 34. [Efficacy of raltegravir: from healthy volunteers to phase III trials].
    Gatell JM.
    Enferm Infecc Microbiol Clin; 2008 Nov 14; 26 Suppl 12():29-33. PubMed ID: 19572423
    [Abstract] [Full Text] [Related]

  • 35. Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor-, protease inhibitor-, and raltegravir-based antiretroviral regimens.
    Patel N, Abdelsayed S, Veve M, Miller CD.
    Ann Pharmacother; 2011 Mar 14; 45(3):317-24. PubMed ID: 21386025
    [Abstract] [Full Text] [Related]

  • 36. Integrase inhibitors: a novel class of antiretroviral agents.
    Schafer JJ, Squires KE.
    Ann Pharmacother; 2010 Jan 14; 44(1):145-56. PubMed ID: 20040702
    [Abstract] [Full Text] [Related]

  • 37. Early emergence of raltegravir resistance mutations in patients receiving HAART salvage regimens.
    Baldanti F, Paolucci S, Gulminetti R, Brandolini M, Barbarini G, Maserati R.
    J Med Virol; 2010 Jan 14; 82(1):116-22. PubMed ID: 19950236
    [Abstract] [Full Text] [Related]

  • 38. Transmitted raltegravir resistance in an HIV-1 CRF_AG-infected patient.
    Boyd SD, Maldarelli F, Sereti I, Ouedraogo GL, Rehm CA, Boltz V, Shoemaker D, Pau AK.
    Antivir Ther; 2011 Jan 14; 16(2):257-61. PubMed ID: 21447876
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The use of HIV-1 integrase inhibitors in antiretroviral naive patients.
    Lennox JL.
    Curr Opin HIV AIDS; 2012 Sep 14; 7(5):409-14. PubMed ID: 22789985
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.